Table 1 Main characteristics of the population study
Characteristics, n = 111 | stable weight (n = 77) | changing weight (n = 34) | P | |
|---|---|---|---|---|
Median age (years (range)) | 54 (32 - 74) | 53 (37 - 70) | 54 (32 - 74) | 0,49 |
n (%) | ||||
Median BMI | 24.4 (17.1 - 40.5) | 24.6 (17.1 - 40.5) | 24.4 (16.6 - 40.5) | 0,14 |
underweight | 9 (8) | 7 (9) | 2 (6) | |
normal | 56 (50) | 36 (47) | 20 (59) | |
overweight | 31 (28) | 21 (27) | 10 (29) | |
obese | 15 (14) | 13 (17) | 2 (6) | |
Menopausal status | 0,78 | |||
Premenopausal | 50 (45) | 34 (44) | 16 (47) | |
Menopausal | 61 (55) | 43 (56) | 18 (53) | |
Oestrogene receptors | 0,61 | |||
Positive | 47 (42) | 32 (42) | 15 (44) | |
Negative | 48 (44) | 35 (45) | 13 (38) | |
Progesteron receptors | 0,73 | |||
Positive | 39 (35) | 29 (38) | 10 (29) | |
Negative | 52 (47) | 37 (48) | 15 (44) | |
Tumor stage | 0,99 | |||
T1 | 21 (19) | 15 (19) | 6 (18) | |
T2 | 49 (44) | 34 (44) | 15 (44) | |
T3 | 17 (15) | 12 (16) | 5 (18) | |
T4 | 24 (22) | 16 (21) | 8 (24) | |
Clinical node involvement | 0,34 | |||
N0 | 55 (50) | 34 (44) | 21 (62) | |
N1 | 49 (44) | 37 (48) | 12 (35) | |
N2 | 6 (5) | 5 (6) | 1 (3) | |
N3 | 1 (1) | 1 (1) | ||
SBR grade | 0,17 | |||
I | 9 (8) | 8 (10) | 1 (3) | |
II | 61 (55) | 40 (52) | 21 (62) | |
III | 22 (20) | 8 (10) | 4 (12) |